Colgate director awarded shares and stock options

Colgate-Palmolive director Lorrie M. Norrington reported compensation-related equity awards.

Rhea-AI Filing Summary

Colgate-Palmolive director Lorrie M. Norrington reported compensation-related equity awards. She received an annual director stock grant of 2,075 shares of common stock credited to a stock unit account under the company’s incentive compensation plan, bringing her direct common stock holdings to 42,312 shares.

She was also granted a stock option covering 2,424 shares of common stock at an exercise price of $86.74 per share. This option expires on May 11, 2034 and becomes exercisable in equal annual installments over three years, beginning on the first anniversary of the May 11, 2026 grant date.

Insider Trade Summary

Grant/Award: 4,499 shares

Grant/Award 2 txns

Insider NORRINGTON LORRIE M

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (Right to Buy)	2,424	$0.00	$0.00
Grant/Award	Common Stock	2,075	$0.00	$0.00

Holdings After Transaction: Stock Option (Right to Buy) — 2,424 contracts (Direct); Common Stock — 42,312 shares (Direct)

Footnotes (3)

1. F1. Annual director stock grant under the issuer's incentive compensation plan, credited to a stock unit account pursuant to the issuer's incentive compensation plan.
2. F2. Annual director stock option grant under the issuer's incentive compensation plan.
3. F3. Option becomes exercisable in equal annual installments over three years beginning on the first anniversary of the May 11, 2026 grant date.

Key Figures

Director stock grant: 2,075 shares Stock option grant size: 2,424 shares Option exercise price: $86.74 per share +2 more

5 metrics

Director stock grant 2,075 shares Annual director stock grant on May 11, 2026

Stock option grant size 2,424 shares Stock Option (Right to Buy) granted on May 11, 2026

Option exercise price $86.74 per share Exercise price for 2,424-share stock option

Option expiration May 11, 2034 Expiration date of stock option grant

Shares held after grant 42,312 shares Total common stock directly held after stock grant

Key Terms

Annual director stock grant, stock unit account, incentive compensation plan, Stock Option (Right to Buy), +1 more

5 terms

Annual director stock grant financial

"Annual director stock grant under the issuer's incentive compensation plan"

stock unit account financial

"credited to a stock unit account pursuant to the issuer's incentive compensation plan"

incentive compensation plan financial

"under the issuer's incentive compensation plan, credited to a stock unit account"

An incentive compensation plan is a formal program that rewards employees and executives with bonuses, stock, or other payments tied to specific performance goals—such as revenue, profit, productivity, or long‑term share price. Investors watch these plans because they shape how leaders make decisions and take risks; like paying a coach by wins rather than effort, well‑designed plans can drive sustainable growth while poor designs can encourage short‑term behaviors that harm shareholder value.

Stock Option (Right to Buy) financial

"Stock Option (Right to Buy) as a derivative security granted on May 11, 2026"

exercisable in equal annual installments financial

"Option becomes exercisable in equal annual installments over three years"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What equity awards did Lorrie M. Norrington receive from Colgate-Palmolive (CL)?

Lorrie M. Norrington received 2,075 shares of Colgate-Palmolive common stock as an annual director stock grant and a stock option for 2,424 shares at an exercise price of $86.74 per share, both granted under the company’s incentive compensation plan.

How many Colgate-Palmolive (CL) shares does Lorrie M. Norrington now hold directly?

After the reported grant, Lorrie M. Norrington directly holds 42,312 shares of Colgate-Palmolive common stock. This reflects the addition of 2,075 shares from the annual director stock grant credited to her stock unit account under the company’s incentive compensation plan.

What are the terms of Lorrie M. Norrington’s new Colgate-Palmolive (CL) stock option?

The new stock option covers 2,424 shares of Colgate-Palmolive common stock at an exercise price of $86.74 per share. It expires on May 11, 2034 and vests in equal annual installments over three years starting on the first anniversary of the May 11, 2026 grant date.

Is Lorrie M. Norrington’s Form 4 for Colgate-Palmolive (CL) an open-market purchase or sale?

The Form 4 reflects compensation-related acquisitions, not open-market trades. It shows an annual director stock grant of 2,075 shares and a stock option grant for 2,424 shares, both awarded under Colgate-Palmolive’s incentive compensation plan rather than bought or sold in the market.

How does the Colgate-Palmolive (CL) stock option granted to Lorrie M. Norrington vest?

The stock option granted to Lorrie M. Norrington vests in equal annual installments over three years. Vesting begins on the first anniversary of the May 11, 2026 grant date, aligning with typical multi-year vesting schedules for director equity compensation at large public companies.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/13/2026 - 04:46 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

NORRINGTON LORRIE M

(Last) (First) (Middle)

C/O COLGATE-PALMOLIVE COMPANY

300 PARK AVENUE

(Street)

NEW YORK NEW YORK 10022

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
COLGATE PALMOLIVE CO [ CL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/11/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/11/2026		A(1)		2,075	A	$0.0000	42,312	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$86.74	05/11/2026		A(2)		2,424		(3)	05/11/2034	Common Stock	2,424	$0.0000	2,424	D

Explanation of Responses:

1. Annual director stock grant under the issuer's incentive compensation plan, credited to a stock unit account pursuant to the issuer's incentive compensation plan.

2. Annual director stock option grant under the issuer's incentive compensation plan.

3. Option becomes exercisable in equal annual installments over three years beginning on the first anniversary of the May 11, 2026 grant date.

	/s/ Kristine Hutchinson, Attorney-in-Fact	05/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)